Top compounds associated with response to UBD


Feature Type Standardized
Nominal ANOVA
mRNA SGX-523 CTRPv2 pan-cancer AAC -0.037 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA UNC0321 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA gossypol CTRPv2 pan-cancer AAC -0.036 0.3
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.3
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.036 0.3
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.033 0.3
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.078 0.4
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.076 0.4
Download CSV